HPV vaccination has long been framed as a way to prevent cervical cancer in women, but the virus causes a range of cancers ...

Please provide your email address to receive an email when new articles are posted on . Expanding HPV vaccination to all adults aged 27 to 45 years would cost more than $2 million per QALY.

For years, the HPV vaccine was framed primarily as protection against cervical cancer. Findings presented at the American ...

The human papillomavirus (HPV), a common sexually transmitted infection, accounts for 70% of all throat cancers, according to the National Cancer Institute. While commonly associated with cervical ...

Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and can cause various types of cancer. Prophylactic HPV vaccination is highly effective and has been recommended ...

(HealthDay News) — Men have a higher prevalence of oncogenic oral human papillomavirus (HPV) than women, and prevalence increases with the number of lifetime oral sexual partners and tobacco use, ...

When compared with unvaccinated patients, HPV vaccines were associated with lower rates of HPV-related cancer for people younger than 40. People younger than 40 who received a human papillomavirus ...

As part of the European Vaccination Week, which will take place from April 19 to 25, 2026, Luxembourg announces the extension of its vaccination program against the human papillomavirus (HPV).

Researchers conducted an observational convenience sampling study on 452 UK-based young adults residing in East Midlands, UK, and enrolled in graduate or post-graduates courses at the University of ...

The award-winning Fort Worth chef says there’s a simple way to prevent cases of head and neck cancer like the one he just ...